drugset / Trial / NCT00038090
Thalidomide-Dexamethasone for Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Objective is to assess the activity of the combination of thalidomide and dexamethasone in patients with previously untreated multiple myeloma.
Timeline
- Start
- 2000-06
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 20 mg/m2 | Oral |
| Subject | Thalidomide | Other / unclassified | 100 mg | Oral |